Abstract |
CD8(+) effector T cells recognize malignant cells by monitoring their surface for the presence of tumor-derived peptides bound to MHC class I molecules. In addition, tumor-derived Ags can be cross-presented to CD8(+) effector T cells by APCs. IFN-gamma production by CD8(+) T cells is often critical for tumor rejection. However, it remained unclear whether 1) CD8(+) T cells secrete IFN-gamma in response to Ag recognition on tumor cells or APCs and 2) whether IFN-gamma mediates its antitumor effect by acting on host or tumor cells. We show in this study that CD8(+) effector T cells can reject tumors in bone marrow-chimeric mice incapable of cross-presenting Ag by bone marrow-derived APCs and that tumor rejection required host cells to express IFN-gammaR. Together, CD8(+) effector T cells recognize Ag directly on tumor cells, and this recognition is sufficient to reject tumors by IFN-gamma acting on host cells.
|
Authors | Thomas Schüler, Thomas Blankenstein |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 170
Issue 9
Pg. 4427-31
(May 01 2003)
ISSN: 0022-1767 [Print] United States |
PMID | 12707316
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Neoplasm
- Receptors, Interferon
- interferon gamma receptor
- Interferon-gamma
- Ovalbumin
|
Topics |
- Animals
- Antigen Presentation
(immunology)
- Antigen-Presenting Cells
(immunology, metabolism)
- Antigens, Neoplasm
(immunology, metabolism)
- Bone Marrow Cells
(immunology, metabolism)
- CD8-Positive T-Lymphocytes
(immunology)
- Cells, Cultured
- Graft Rejection
(immunology)
- Interferon-gamma
(metabolism, physiology)
- Melanoma, Experimental
(immunology, metabolism, prevention & control)
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Mice, Transgenic
- Neoplasm Transplantation
- Ovalbumin
(immunology, metabolism)
- Receptors, Interferon
(biosynthesis, physiology)
- Tumor Cells, Cultured
|